{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:55:21Z","timestamp":1778583321415,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuropharm.2020.108109","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T20:31:18Z","timestamp":1587414678000},"page":"108109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of pituitary adenylyl cyclase-activating polypeptide in the motivational effects of addictive drugs"],"prefix":"10.1016","volume":"171","author":[{"given":"Andrea","family":"Stojakovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muzzammil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mudassir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabirullah","family":"Lutfy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108109_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbrainres.2005.03.016","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene","volume":"138","author":"Agarwal","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108109_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/FBP.0b013e32835cf3e5","article-title":"The selective metabotropic glutamate 2\/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptide","volume":"24","author":"Ago","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-0115(92)90621-Z","article-title":"Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research","volume":"37","author":"Arimura","year":"1992","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108109_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1749-6632.1994.tb19825.x","article-title":"PACAP functions as a neurotrophic factor","volume":"739","author":"Arimura","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0196-9781(00)00153-4","article-title":"Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression","volume":"21","author":"Benoit","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neuron.2013.07.018","article-title":"Alcohol and tobacco: how smoking may promote excessive drinking","volume":"79","author":"Britt","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108109_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-8993(92)91487-Y","article-title":"Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role","volume":"597","author":"Cador","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108109_bib8","doi-asserted-by":"crossref","first-page":"14165","DOI":"10.1523\/JNEUROSCI.1402-12.2012","article-title":"Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit","volume":"32","author":"Cho","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0014-4886(03)00300-5","article-title":"Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission","volume":"184","author":"Ciranna","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1054\/npep.2002.0885","article-title":"Transcriptional and post-transcriptional regulation of tyrosine hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways","volume":"36","author":"Corbitt","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245149","article-title":"The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine","volume":"107","author":"Corrigall","year":"1992","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2020.108109_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","article-title":"Role of dopamine in the behavioural actions of nicotine related to addiction","volume":"393","author":"Di Chiara","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.15288\/jsa.1990.51.130","article-title":"Alcoholism and smoking","volume":"51","author":"DiFranza","year":"1990","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.neuropharm.2020.108109_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(98)00602-5","article-title":"Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine","volume":"358","author":"Ericson","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.108.137489","article-title":"Nicotinic acetylcholine receptors in the anterior, but not posterior, ventral tegmental area mediate ethanol-induced elevation of accumbal dopamine levels","volume":"326","author":"Ericson","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108109_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)01564-4","article-title":"Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors","volume":"467","author":"Ericson","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuropharm.2013.09.008","article-title":"Nicotine aversion: neurobiological mechanisms and relevance to tobacco dependence vulnerability","volume":"76 Pt B","author":"Fowler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108109_bib18","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.peptides.2007.06.012","article-title":"Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice","volume":"28","author":"Fujii","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.11.046","volume":"202","author":"Gaszner","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108109_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1360159","article-title":"Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues","volume":"136","author":"Ghatei","year":"1993","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0006-8993(97)01011-1","article-title":"Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus","volume":"773","author":"Grinevich","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108109_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.npep.2008.04.003","article-title":"PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity","volume":"42","author":"Guillot","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/acer.13826","article-title":"Pituitary adenylate cyclase-activating polypeptide-27 (PACAP-27) in the thalamic paraventricular nucleus is stimulated by ethanol drinking","volume":"42","author":"Gupta","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108109_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cne.10418","article-title":"Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study","volume":"453","author":"Hannibal","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(24)01360-7","article-title":"International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108109_bib26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1530-0277.2008.00796.x","article-title":"Nondaily smoking and alcohol use, hazardous drinking, and alcohol diagnoses among young adults: findings from the NESARC","volume":"32","author":"Harrison","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108109_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.addbeh.2007.11.012","article-title":"Young adult non-daily smokers: patterns of alcohol and cigarette use","volume":"33","author":"Harrison","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2020.108109_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1471-4159.2009.06168.x","article-title":"Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone","volume":"110","author":"Hashimoto","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108109_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1196\/annals.1317.038","article-title":"New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice","volume":"1070","author":"Hashimoto","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib30","doi-asserted-by":"crossref","first-page":"13355","DOI":"10.1073\/pnas.231094498","article-title":"Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)","volume":"98","author":"Hashimoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108109_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neulet.2009.11.019","article-title":"Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder","volume":"468","author":"Hashimoto","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108109_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnbeh.2012.00058","article-title":"Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice","volume":"6","author":"Hattori","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cne.902220407","article-title":"Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons","volume":"222","author":"Hokfelt","year":"1984","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(99)00024-5","article-title":"Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract","volume":"84","author":"Lauff","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108109_bib35","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1523\/JNEUROSCI.3302-14.2015","article-title":"Chronic nicotine activates stress\/reward-related brain regions and facilitates the transition to compulsive alcohol drinking","volume":"35","author":"Leao","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.npep.2011.12.001","article-title":"The effect of pituitary adenylate cyclase-activating polypeptide on elevated plus maze behavior and hypothermia induced by morphine withdrawal","volume":"46","author":"Liptak","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.pmbts.2019.06.009","article-title":"Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders","volume":"167","author":"Lutfy","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.neuropharm.2020.108109_bib38","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1523\/JNEUROSCI.3871-05.2005","article-title":"Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src","volume":"25","author":"Macdonald","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0167-0115(02)00187-8","article-title":"The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice","volume":"109","author":"Macsai","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108109_bib40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-009-1476-9","article-title":"The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice","volume":"204","author":"Marquez","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2020.108109_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-328X(02)00646-0","article-title":"Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice","volume":"110","author":"Martin","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108109_bib42","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/00001756-200311140-00017","article-title":"Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice","volume":"14","author":"Matsuyama","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.108109_bib43","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/npp.2017.135","article-title":"Pituitary adenylate cyclase-activating peptide in the bed nucleus of the stria terminalis mediates stress-induced reinstatement of cocaine seeking in rats","volume":"43","author":"Miles","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108109_bib44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biopsych.2016.08.025","article-title":"Parabrachial pituitary adenylate cyclase-activating polypeptide activation of amygdala endosomal extracellular signal-regulated kinase signaling regulates the emotional component of pain","volume":"81","author":"Missig","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108109_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"Miyata","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.108109_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1054\/npep.1999.0768","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP-27) enhances tyrosine hydroxylase activity in the nucleus accumbens of the rat","volume":"33","author":"Moser","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2020.108109_bib47","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1523\/JNEUROSCI.21-15-05520.2001","article-title":"Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice","volume":"21","author":"Otto","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(01)00153-X","article-title":"Altered emotional behavior in PACAP-type-I-receptor-deficient mice","volume":"92","author":"Otto","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108109_bib49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0169-328X(99)00010-8","article-title":"Presynaptic localization of the PACAP-typeI-receptor in hippocampal and cerebellar mossy fibres","volume":"66","author":"Otto","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108109_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.mcn.2009.11.007","article-title":"PACAP\/PAC(1)R signaling modulates acetylcholine release at neuronal nicotinic synapses","volume":"43","author":"Pugh","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1101\/lm.34200","article-title":"PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region","volume":"7","author":"Roberto","year":"2000","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.108109_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1101\/lm.40501","article-title":"Differential effects of PACAP-38 on synaptic responses in rat hippocampal CA1 region","volume":"8","author":"Roberto","year":"2001","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.108109_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2015.08.043","article-title":"Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons","volume":"308","author":"Saghy","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108109_bib54","first-page":"619","article-title":"The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)\/glucagon superfamily","volume":"21","author":"Sherwood","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2020.108109_bib55","first-page":"487","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain","volume":"75","author":"Shioda","year":"2000","journal-title":"Kaibogaku Zasshi"},{"key":"10.1016\/j.neuropharm.2020.108109_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0169-328X(02)00400-X","article-title":"Resistance to alcohol withdrawal-induced behaviour in Fyn transgenic mice and its reversal by ifenprodil","volume":"105","author":"Stork","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108109_bib57","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2826.2011.02202.x","article-title":"Pituitary adenylate cyclase-activating polypeptide controls stimulus-transcription coupling in the hypothalamic-pituitary-adrenal axis to mediate sustained hormone secretion during stress","volume":"23","author":"Stroth","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108109_bib58","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1749-6632.1998.tb11238.x","article-title":"The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice","volume":"865","author":"Szabo","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.regpep.2004.05.017","article-title":"Reduced hypothermic and hypnotic responses to ethanol in PACAP-deficient mice","volume":"123","author":"Tanaka","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108109_bib60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2009.11.136","article-title":"Increased ethanol preference and serotonin 1A receptor-dependent attenuation of ethanol-induced hypothermia in PACAP-deficient mice","volume":"391","author":"Tanaka","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.108109_bib61","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1523\/JNEUROSCI.4376-05.2006","article-title":"Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice","volume":"26","author":"Tanaka","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib62","doi-asserted-by":"crossref","first-page":"RC75","DOI":"10.1523\/JNEUROSCI.20-10-j0003.2000","article-title":"High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice","volume":"20","author":"Thiele","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108109_bib63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/alcalc\/agm057","article-title":"Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell","volume":"42","author":"Tizabi","year":"2007","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2020.108109_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s12640-017-9859-x","article-title":"Low Vs. High alcohol: central benefits Vs. Detriments","volume":"34","author":"Tizabi","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2020.108109_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1742-4658.2011.08391.x","article-title":"Regulation of NMDA receptors by the tyrosine kinase Fyn","volume":"279","author":"Trepanier","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2020.108109_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2019.04.007","article-title":"The role of endogenous pituitary adenylyl cyclase activating polypeptide (PACAP) in nicotine self-administration, reward and aversion","volume":"181","author":"Tseng","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108109_bib67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(24)01449-2","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108109_bib68","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1074\/jbc.M209141200","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1","volume":"278","author":"Yaka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108109_bib69","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12031-010-9372-7","article-title":"The involvement of PACAP\/VIP system in the synaptic transmission in the hippocampus","volume":"42","author":"Yang","year":"2010","journal-title":"J. Mol. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820301775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:02:26Z","timestamp":1758438146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820301775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":69,"alternative-id":["S0028390820301775"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108109","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of pituitary adenylyl cyclase-activating polypeptide in the motivational effects of addictive drugs","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108109"}}